Shanghai Zhongshan Hospital: Liver Cirrhosis trials

The registry lists 10 Liver Cirrhosis studies with Shanghai Zhongshan Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 4 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Gastric Variceal Ligation Versus Gastric Variceal Obturation for Secondary Prophylaxis of Gastric VaricesStatus unknownNCT03729921Not applicable
• The Effect of Calcium β-hydroxy-β-methylbutyrate (CaHMB) Supplementation in Sarcopenia in Liver CirrhosisStatus unknownNCT03605147Not applicable
• Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionStatus unknownNCT03277651
• The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal BleedingStatus unknownNCT02695732Phase 4
• The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric VaricesStatus unknownNCT02638415Phase 4
• The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCTStatus unknownNCT02630095Phase 4
• The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein ThrombosisStatus unknownNCT02398357Phase 4
• The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal BleedingStatus unknownNCT02385422Phase 4
• Effects of Terlipressin When Usual Somatostatin or Octreotide Dose FailsStatus unknownNCT02311608
• The Research of the Evaluation of Clinical Procedures in Gastroesophageal Varices in Patients With Liver CirrhosisStatus unknownNCT01592578Not applicable